UK pharma investment crisis: Why Big Pharma is pulling billions from the UK

Rising costs, unpredictable policies, and dwindling incentives are forcing Big Pharma to rethink the UK, with leading firms pausing multi-million-pound R&D projects, but why is the country losing its competitive edge?

Advertisements



Latest Academic Articles

The latest academic articles from a wide range of themes such as energy, environment, health, agriculture, social sciences and technology plus more.

Open Access eBooks

The latest open access and free to distribute eBooks from key industry stakeholders covering health, energy, environment, plus more.

Horizon Europe

COP Climate Change

Special Reports